Committed to creating long-term shareholder value through the strategic development of transformative therapeutics.
Access our financial disclosures, governance documents, and recent company news.
Review quarterly earnings, annual reports, and comprehensive SEC filings.
View Reports →Learn about our board of directors, committee charters, and code of conduct.
Governance Overview →Stay updated with our latest clinical milestones and corporate updates.
Read Latest News →Official regulatory documents submitted to the Securities and Exchange Commission.
| Filing Type | Filing Description | Filing Date | Download |
|---|---|---|---|
| 10-K | Annual Report for Fiscal Year Ended December 31 | Mar 28, 2026 | PDF (2.4 MB) |
| 10-Q | Quarterly Report for Period Ended September 30 | Nov 14, 2025 | PDF (1.1 MB) |
| 8-K | Current Report: Disclosure of Material Events | Aug 05, 2025 | PDF (450 KB) |
| 10-Q | Quarterly Report for Period Ended June 30 | Aug 12, 2025 | PDF (1.3 MB) |
For investor inquiries, corporate presentation requests, or to join our distribution list, please reach out directly to our IR team.
Contact Investor Relations